Story · Medicine & Biotech

Decades in the making, MCAM enters initial human testing

1 outlet · first reported by UT Health San Antonio News 1d ago

Coverage, in order

  1. 1d ago
    Decades in the making, MCAM enters initial human testing

    After several years of development, a promising drug designed to prevent relapse to opioid use and opioid overdose is taking a critical step by entering human testing. In October, scientists at The University of Texas at San Antonio Health Science Center launched the first-in-human clinical trial…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.